Now, with the ability to measure coronary inflammation through AI-enhanced CT scans and to more accurately determine a person's risk of heart attack, we can intervene earlier and more effectively.
The FDA asked Cytokinetics for the Risk Evaluation and Mitigation Strategy after it had already accepted the application for aficamten, a potential competitor to Bristol Myers Squibbs heart drug Camzyos. Analysts say this development could signal a change in FDA thinking about risk management for the broader drug class.
This eBook provides actionable strategies, real-world best practices to help payers stay ahead in a value-based care environment.
Many new tech solutions, such as wearables and algorithms, have emerged in recent years to address the country’s heart disease problem. While it’s easy to get excited about technology’s potential to improve cardiac care, there are a few things that healthcare leaders must keep in mind, according to Dr. Sumeet Chugh, director of the Heart Institute and director of AI in medicine at Cedars-Sinai.
it is paramount that we address both cholesterol risk and inflammation to reduce the risk of a heart attack or stroke.
In a recent webinar sponsored by 100Plus, the healthcare company provided a roadmap on how their RPM program works, including device deployment, collaboration with clinicians, implementation and reimbursement.
Mayo Clinic shared results of a study showing that an AI tool developed by the system could be used to improve diagnosis of low ejection fraction, a type of heart disease. It's part of a broader push by Mayo Clinic to commercialize AI-based diagnostic tools, starting with spinout company Anumana.
Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.
The Illinois-based health system is teaming up with the analytics company to launch a genomics program, which will focus on predicting the risk of illness and outcomes among patients. It will also provide free genetic testing to low-income patients in an effort to increase access to genomic care.
Heartbeat Health, a digital health startup to help patients manage heart disease, raised $8.2 million in series A funding. The platform offers telehealth visits and helps patients keep track of their heart health by pulling in metrics from wearables and other devices.
The algorithm — which measures variations in heart rate — is designed to predict heart problems, but a cardiologist wonders whether it can outperform other risk factors.
While the development of renal denervation technologies stalled after a failed Medtronic study in 2014, recent positive research results have led to increasing interest - and investment - in the space.
Scheduling software is helpful for wellness business owners in numerous ways. They get everything they need to create appointments, reschedule clients and track cancellations in one platform.
The new Japanese reimbursement policy will go into effect on Dec. 1 and follows positive coverage decisions by Medicare and the United Kingdom’s National Health Services.
The tool harnesses Mayo Clinic's cardiovascular database and expertise in heart disease screening combined with Eko's cardiac monitoring platform.
Apple Watch's entry into the device world garnered a ton of attention and praise, but a good portion of observers have reservations about whether it will truly move the needle in healthcare.
In addition to the acquisition, Quest Diagnostics and the Cleveland Clinic have embarked on a strategic collaboration that will evaluate biomarkers for various diseases, with Quest developing tests for some of them.
Color Genomics' latest test highlights the quandary of genetic testing colliding with value-based care: Is the push to test taking preventive medicine in the wrong direction?